Cooper Companies Inc (COO): Albert G Iii White , EVP & Chief Strategy Officer of Cooper Companies Inc sold 20,000 shares on Sep 14, 2016. The Insider selling transaction was reported by the company on Sep 14, 2016 to the Securities and Exchange Commission. The shares were sold at $185.72 per share for a total value of $3,714,482.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 7, 2016, Stanley Md Zinberg (director) sold 3,000 shares at $187.53 per share price.On Sep 7, 2016, Gary S Petersmeyer (director) sold 530 shares at $186.50 per share price.Also, On Sep 7, 2016, William A Kozy (director) purchased 270 shares at $186.69 per share price.On Sep 7, 2016, Michael Kalkstein (director) sold 6,544 shares at $187.14 per share price.
Cooper Companies Inc: On Monday, Sep 12, 2016 heightened volatility was witnessed in Cooper Companies Inc which led to swings in the share price. The shares opened for trading at $184.6 and hit $186.9 on the upside , eventually ending the session at $186.74, with a gain of 1.03% or 1.91 points. The heightened volatility saw the trading volume jump to 319,923 shares. The 52-week high of the share price is $189.98 and the company has a market cap of $9,102 M . The 52-week low of the share price is at $119.28.
Company has been under the radar of several Street Analysts.Cooper Companies Inc is Reiterated by BMO Capital Markets to Outperform and the brokerage firm has raised the Price Target to $ 206 from a previous price target of $199 .The Rating was issued on Sep 2, 2016.Cooper Companies Inc is Reiterated by Stifel to Buy and the brokerage firm has raised the Price Target to $ 215 from a previous price target of $195 .The Rating was issued on Aug 31, 2016.Cooper Companies Inc is Reiterated by Stifel to Buy and the brokerage firm has raised the Price Target to $ 195 from a previous price target of $180 .The Rating was issued on Jun 30, 2016.
The Cooper Companies Inc. (Cooper) is a global medical device company. The Company operates through two business units CooperVision Inc. (CVI) and CooperSurgical Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women’s health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital Office and Fertility Clinic. CooperVision develops manufactures and markets a range of monthly two-week and single-use contact lenses featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism presbyopia and ocular dryness and provides innovative contact lens solutions. The CooperVision Companys brands include Biofinity Avaira and MyDay and CooperSurgical Companys brands include Advincula Arch SeeClear and Mobius.